Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0025 USD | 0.00% | 0.00% | +92.31% |
2023 | Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. | CI |
2023 | Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+92.31% | 5.54K | |
-12.42% | 19.08B | |
-46.69% | 2.65B | |
+17.50% | 1.87B | |
-0.58% | 1.61B | |
+25.36% | 1.21B | |
-8.67% | 1.02B | |
-21.91% | 905M | |
-4.42% | 716M | |
-17.27% | 682M |
- Stock Market
- Equities
- HTGMQ Stock
- News HTG Molecular Diagnostics, Inc.
- HTG Molecular Diagnostics : HC Wainwright Adjusts HTG Molecular Diagnostics' Price Target to $9 From $11, Keeps Buy Rating